Huiqiang Liu

499 total citations
31 papers, 285 citations indexed

About

Huiqiang Liu is a scholar working on Cancer Research, Epidemiology and Obstetrics and Gynecology. According to data from OpenAlex, Huiqiang Liu has authored 31 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 8 papers in Epidemiology and 7 papers in Obstetrics and Gynecology. Recurrent topics in Huiqiang Liu's work include Pregnancy and preeclampsia studies (5 papers), Cervical Cancer and HPV Research (5 papers) and MicroRNA in disease regulation (4 papers). Huiqiang Liu is often cited by papers focused on Pregnancy and preeclampsia studies (5 papers), Cervical Cancer and HPV Research (5 papers) and MicroRNA in disease regulation (4 papers). Huiqiang Liu collaborates with scholars based in China, United States and Hong Kong. Huiqiang Liu's co-authors include Yonghong Wang, Min Hao, Wenhao Wang, Chongdong Liu, Dongyan Li, Weihong Zhao, Wenli Zhou, Jintao Wang, Xiaowei Li and Lanlan Wang and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and European Journal of Medicinal Chemistry.

In The Last Decade

Huiqiang Liu

30 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huiqiang Liu China 11 108 80 72 67 64 31 285
Maria Grazia Centurioni Italy 10 73 0.7× 73 0.9× 48 0.7× 24 0.4× 64 1.0× 23 308
Theofano Orfanelli United States 9 103 1.0× 49 0.6× 83 1.2× 55 0.8× 115 1.8× 31 352
Franco Gorlero Italy 10 143 1.3× 85 1.1× 50 0.7× 74 1.1× 20 0.3× 24 383
Masaya Uno Japan 10 70 0.6× 146 1.8× 34 0.5× 42 0.6× 35 0.5× 47 334
Tatsuo Masuda Japan 8 61 0.6× 41 0.5× 43 0.6× 29 0.4× 67 1.0× 17 221
Jiang‐Feng Ye China 10 123 1.1× 152 1.9× 29 0.4× 63 0.9× 220 3.4× 16 395
Martin Koch Germany 8 64 0.6× 49 0.6× 34 0.5× 41 0.6× 22 0.3× 18 254
Hélène van Meir Netherlands 6 74 0.7× 57 0.7× 84 1.2× 31 0.5× 205 3.2× 9 399
Guanyu Ruan China 13 109 1.0× 41 0.5× 186 2.6× 70 1.0× 18 0.3× 25 374
Anja Ernst Denmark 11 93 0.9× 23 0.3× 88 1.2× 16 0.2× 57 0.9× 27 302

Countries citing papers authored by Huiqiang Liu

Since Specialization
Citations

This map shows the geographic impact of Huiqiang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiqiang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiqiang Liu more than expected).

Fields of papers citing papers by Huiqiang Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiqiang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiqiang Liu. The network helps show where Huiqiang Liu may publish in the future.

Co-authorship network of co-authors of Huiqiang Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Huiqiang Liu. A scholar is included among the top collaborators of Huiqiang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiqiang Liu. Huiqiang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Xin, Wencai Guan, Huiqiang Liu, et al.. (2024). Targeting PNPO to suppress tumor growth via inhibiting autophagic flux and to reverse paclitaxel resistance in ovarian cancer. APOPTOSIS. 29(9-10). 1546–1563. 1 indexed citations
4.
Li, Ping, Huiqiang Liu, Ying Zheng, et al.. (2024). Rapid Characterization of the Constituents in Shenhua Tablets by UHPLC‐Q‐Orbitrap‐LTQ‐MS. Journal of Separation Science. 47(23). e70030–e70030. 3 indexed citations
5.
Liu, Huiqiang, Ping Li, Hui Sun, et al.. (2024). In vivo components analysis of Shenhua tablets active in IgA nephropathy. Pharmacological Research - Modern Chinese Medicine. 12. 100493–100493. 1 indexed citations
6.
Guan, Wencai, Jia Yuan, Xin Li, et al.. (2023). Cyclin dependent kinase 14 as a paclitaxel-resistant marker regulated by the TGF-β signaling pathway in human ovarian cancer. Journal of Cancer. 14(13). 2538–2551. 1 indexed citations
7.
Li, Xin, Jia Yuan, Xiaolin Xu, et al.. (2022). The miR-33a-5p/CROT axis mediates ovarian cancer cell behaviors and chemoresistance via the regulation of the TGF-β signal pathway. Frontiers in Endocrinology. 13. 950345–950345. 7 indexed citations
8.
Liu, Huiqiang, Wenhao Wang, & Chongdong Liu. (2020). Increased expression of IFN‑γ in preeclampsia impairs human trophoblast invasion via a SOCS1/JAK/STAT1 feedback loop. Experimental and Therapeutic Medicine. 21(2). 112–112. 25 indexed citations
9.
Yang, Aimin, H. J. Yang, Weihong Zhao, et al.. (2020). Dietary nutrient intake related to higher grade cervical intraepithelial neoplasia risk: a Chinese population-based study. Nutrition & Metabolism. 17(1). 100–100. 10 indexed citations
10.
Wang, Yonghong, Jintao Wang, Weihong Zhao, et al.. (2019). Prevalence, genotype distribution and risk factors of cervical HPV infection in Yangqu, China: a population-based survey of 10086 women. Human Vaccines & Immunotherapeutics. 16(7). 1645–1652. 41 indexed citations
11.
Wang, Yonghong, et al.. (2019). miR-141-5p regulate ATF2 via effecting MAPK1/ERK2 signaling to promote preeclampsia. Biomedicine & Pharmacotherapy. 115. 108953–108953. 37 indexed citations
13.
Feng, Yue, Yutong Sun, Wenhui Ma, et al.. (2019). Synthesis and evaluation of pyrimidoindole analogs in umbilical cord blood ex vivo expansion. European Journal of Medicinal Chemistry. 174. 181–197. 15 indexed citations
14.
Yang, Aimin, Yonghong Wang, Jintao Wang, et al.. (2018). Interactions between serum folate and human papillomavirus with cervical intraepithelial neoplasia risk in a Chinese population-based study. American Journal of Clinical Nutrition. 108(5). 1034–1042. 14 indexed citations
15.
Wang, Qingqing, et al.. (2016). Close monitoring of transcutaneous bilirubin ensures better outcome in neonates with hyperbilirubinemia. Zhonghua weichan yixue zazhi. 19(11). 808–812. 1 indexed citations
16.
Liu, Huiqiang, et al.. (2015). Predictive Value of Free β-hCG Multiple of the Median for Women with Preeclampsia. Gynecologic and Obstetric Investigation. 81(2). 137–147. 15 indexed citations
17.
Wang, Yonghong, Xukui Yang, Yuanyuan Yang, et al.. (2015). High-throughput deep screening and identification of four peripheral leucocyte microRNAs as novel potential combination biomarkers for preeclampsia. Journal of Perinatology. 36(4). 263–267. 10 indexed citations
18.
Liu, Huiqiang, Yonghong Wang, Lanlan Wang, & Min Hao. (2015). P16INK4A and survivin: Diagnostic and prognostic markers in cervical intraepithelial neoplasia and cervical squamous cell carcinoma. Experimental and Molecular Pathology. 99(1). 44–49. 15 indexed citations
19.
Liu, Huiqiang, et al.. (2012). Phase retrieval for hard X-ray computed tomography of samples with hybrid compositions. Chinese Optics Letters. 10(12). 121101–121104. 15 indexed citations
20.
Yang, H. J., et al.. (2012). Downregulation of chemerin and alleviation of endoplasmic reticulum stress by metformin in adipose tissue of rats. Diabetes Research and Clinical Practice. 97(2). 267–275. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026